About
DS
(CLICK HERE
FOR SPANISH VERSION)
The following information is from the National Institute
of Child Health and Human Development (NICHD) Website.
For more information from the NICHD, go to www.nichd.nih.gov/ on the
web.
Down Syndrome
Named after John
Langdon Down, the first physician to identify the syndrome, Down syndrome
is the most frequent genetic cause of mild to moderate mental retardation
and associated medical problems and occurs in one out of 800 live births,
in all races and economic groups. Down syndrome is a chromosomal disorder
caused by an error in cell division that results in the presence of
an additional third chromosome 21 or "trisomy 21."
The Chromosomal
Basis of Down Syndrome
To understand why
Down syndrome occurs, the structure and function of the human chromosome
must be understood. The human body is made of cells; all cells contain
chromosomes, structures that transmit genetic information. Most cells
of the human body contain 23 pairs of chromosomes, half of which are
inherited from each parent. Only the human reproductive cells, the sperm
cells in males and the ovum in females, have 23 individual chromosomes,
not pairs. Scientists identify these chromosome pairs as the XX pair,
present in females, and the XY pair, present in males, and number them
1 through 22.
When the reproductive
cells, the sperm and ovum, combine at fertilization, the fertilized
egg that results contains 23 chromosome pairs. A fertilized egg that
will develop into a female contains chromosome pairs 1 through 22, and
the XX pair. A fertilized egg that will develop into a male contains
chromosome pairs 1 through 22, and the XY pair. When the fertilized
egg contains extra material from chromosome number 21, this results
in Down syndrome.
THE GENETIC
VARIATIONS THAT CAN CAUSE DOWN SYNDROME
Three genetic variations
can cause Down syndrome. In most cases, approximately 92% of the time,
Down syndrome is caused by the presence of an extra chromosome 21 in
all cells of the individual. In such cases, the extra chromosome originates
in the development of either the egg or the sperm. Consequently, when
the egg and sperm unite to form the fertilized egg, three--rather than
two--chromosomes 21 are present. As the embryo develops, the extra chromosome
is repeated in every cell. This condition, in which three copies of
chromosome 21 are present in all cells of the individual, is called
trisomy 21.
In approximately
2-4% of cases, Down syndrome is due to mosaic trisomy 21. This situation
is similar to simple trisomy 21, but, in this instance, the extra chromosome
21 is present in some, but not all, cells of the individual. For example,
the fertilized egg may have the right number of chromosomes, but, due
to an error in chromosome division early in embryonic development, some
cells acquire an extra chromosome 21. Thus, an individual with Down
syndrome due to mosaic trisomy 21 will typically have 46 chromosomes
in some cells, but will have 47 chromosomes (including an extra chromosome
21) in others. In this situation, the range of the physical problems
may vary, depending on the proportion of cells that carry the additional
chromosome 21.
CHROMOSOME
21
In trisomy 21 and
mosaic trisomy 21, Down syndrome occurs because some or all of the cells
have 47 chromosomes, including three chromosomes 21. However, approximately
3-4% of individuals with Down syndrome have cells containing 46 chromosomes,
but still have the features associated with Down syndrome. How can this
be? In such cases, material from one chromosome 21 gets stuck or translocated
onto another chromosome, either prior to or at conception. In such situations,
cells from individuals with Down syndrome have two normal chromosomes
21, but also have additional chromosome 21 material on the translocated
chromosome. Thus, there is still too much material from chromosome 21,
resulting in the features associated with Down syndrome. In such situations,
the individual with Down syndrome is said to have translocation trisomy
21.
The Occurrence
of Down Syndrome
Most of the time,
the occurrence of Down syndrome is due to a random event that occurred
during formation of the reproductive cells, the ovum or sperm. As far
as we know, Down syndrome is not attributable to any behavioral activity
of the parents or environmental factors. The probability that another
child with Down syndrome will be born in a subsequent pregnancy is about
1 percent, regardless of maternal age.
The
incidence of Down syndrome rises with increasing maternal age.
For parents of a child with Down syndrome due to translocation trisomy
21, there may be an increased likelihood of Down syndrome in future
pregnancies. This is because one of the two parents may be a balanced
carrier of the translocation. The translocation occurs when a piece
of chromosome 21 becomes attached to another chromosome, often number
14, during cell division. If the resulting sperm or ovum receives a
chromosome 14 (or another chromosome), with a piece of chromosome 21
attached and retains the chromosome 21 that lost a section due to translocation,
then the reproductive cells contain the normal or balanced amount of
chromosome 21. While there will be no Down syndrome associated characteristics
exhibited, the individual who develops from this fertilized egg will
be a carrier of Down syndrome. Genetic counseling can be sought to find
the origin of the translocation.
However, it is important
to realize that not all parents of individuals with translocation trisomy
21 are themselves balanced carriers. In such situations, there is no
increased risk for Down syndrome in future pregnancies.
Researchers have
extensively studied the defects in chromosome 21 that cause Down syndrome.
In 88% of cases, the extra copy of chromosome 21 is derived from the
mother. In 8% of the cases, the father provided the extra copy of chromosome
21. In the remaining 2% of the cases, Down syndrome is due to mitotic
errors, an error in cell division which occurs after fertilization when
the sperm and ovum are joined.
DOWN SYNDROME
AND MATERNAL AGE
Researchers have
established that the likelihood that a reproductive cell will contain
an extra copy of chromosome 21 increases dramatically as a woman ages.
Therefore, an older mother is more likely than a younger mother to have
a baby with Down syndrome. However, of the total population, older mothers
have fewer babies; about 75% of babies with Down syndrome are born to
younger women because more younger women than older women have babies.
Only about nine percent of total pregnancies occur in women 35 years
or older each year, but about 25% of babies with Down syndrome are born
to women in this age group.
The incidence of
Down syndrome rises with increasing maternal age. Many specialists recommend
that women who become pregnant at age 35 or older undergo prenatal testing
for Down syndrome. The likelihood that a woman under 30 who becomes
pregnant will have a baby with Down syndrome is less than 1 in 1,000,
but the chance of having a baby with Down syndrome increases to 1 in
400 for women who become pregnant at age 35. The likelihood of Down
syndrome continues to increase as a woman ages, so that by age 42, the
chance is 1 in 60 that a pregnant woman will have a baby with Down syndrome,
and by age 49, the chance is 1 in 12. But using maternal age alone will
not detect over 75% of pregnancies that will result in Down syndrome.
RELATIONSHIP OF DOWN SYNDROME INCIDENCE TO MOTHERS'
AGE
Mothers Age
Incidence of Down Syndrome
Under 30 Less than 1 in 1,000
30 1 in 900
35 1 in 400
36 1 in 300
37 1 in 230
38 1 in 180
39 1 in 135
40 1 in 105
42 1 in 60
44 1 in 35
46 1 in 20
48 1 in 16
49 1 in 12
Source: Hook, E.G., Lindsjo, A. Down Syndrome in Live Births by
Single Year Maternal Age.
Prenatal
Screening for Down Syndrome
Prenatal screening
for Down syndrome is available. There is a relatively simple, noninvasive
screening test that examines a drop of the mother's blood to determine
if there is an increased likelihood for Down syndrome. This blood test
measures the levels of three markers for Down syndrome: serum alpha
feto-protein (MSAFP), chorionic gonadotropin (hCG), and unconjugated
estriol (uE3). While these measurements are not a definitive test for
Down syndrome, a lower MSAFP value, a lower uE3 level, and an elevated
hCG level, on average, suggests an increased likelihood of a Down syndrome
fetus, and additional diagnostic testing may be desired.
DIAGNOSTIC
TESTING FOR DOWN SYNDROME
There are several
prenatal diagnostic tests that can be performed to determine the occurrence
of Down syndrome. These tests include amniocentesis, chorionic villus
sampling (CVS), and percutaneous umbilical blood sampling (PUBS). However,
before undergoing any of these diagnostic tests, patients and their
families should seek detailed genetic counseling to discuss their family
history in relationship to the risks and benefits of performing these
diagnostic procedures.
Amniocentesis, the
removal and analysis of a small sample of fetal cells from the amniotic
fluid, is widely available and involves a lower risk of miscarriage
than chorionic villus sampling. However, amniocentesis cannot be done
until the 14th to 18th week of pregnancy, and it usually takes additional
time to determine whether the cells contain extra material from chromosome
21.
Chorionic villus
sampling, conducted at 9 to 11 weeks of pregnancy, involves extracting
a tiny amount of chorionic villi, tissue extensions that will eventually
develop into a placenta. The tissue can be tested for the presence of
extra material from chromosome 21. The villi can be obtained through
the pregnant woman's abdomen or cervix. This type of sampling carries
a 1-2% risk of miscarriage.
The third diagnostic
method, percutaneous umbilical blood sampling or PUBS, is the most accurate
method and can be used to confirm the results of CVS or amniocentesis.
However, PUBS cannot be performed until later in the pregnancy, during
the 18th to 22nd weeks, and carries the greatest risk of miscarriage.
New prenatal diagnostic
techniques are currently being developed. The NICHD has supported the
development of a new, noninvasive test performed during the first trimester
of pregnancy, that samples and separates fetal cells from the mother's
blood. The goal is to compare the accuracy of this type of cellular
level analysis with results obtained by amniocentesis or CVS.
DIAGNOSTIC
TESTS FOR DOWN SYNDROME
AMNIOCENTESIS
The removal and analysis of a small sample of fetal cells from the amniotic
fluid.
Cannot be done until the 14-18th week of pregnancy
Lower risk of miscarriage than chorionic villus sampling
CHORIONIC VILLUS SAMPLING (CVS)
Extraction of a tiny amount of fetal tissue at 9 to 11 weeks of pregnancy
The tissue is tested for the presence of extra material from chromosome
21
Carries a 1-2% risk of miscarriage
PERCUTANEOUS UMBILICAL BLOOD SAMPLING (PUBS)
Most accurate method used to confirm the results of CVS or amniocentesis.
The tissue is tested for the presence of extra material from chromosome
21
PUBS cannot be done until the 18-22nd week
Carries the greatest risk of miscarriage
Researchers outside
the NICHD are also developing a new method of diagnosis, called preimplantation
diagnosis or blastomere analysis before implantation (BABI), which allows
clinicians to detect chromosome imbalances before an embryo is implanted
during in vitro fertilization. This technique would primarily be used
in couples who are at risk of passing on X-linked disorders, couples
who have suffered repeated terminations of pregnancy, subfertile couples,
or those at risk for single gene disorders. This technique, which allows
the clinician to provide a genetic diagnosis prior to implantation,
has been successful so far for cystic fibrosis, Tay Sachs disease, and
Lesch-Nyhan syndrome. BABI allows a couple to begin their pregnancy
knowing that the fetus is unaffected with the genetic disease of concern.
For couples at high risk, this procedure provides an alternative to
prenatal testing in the first or second trimester.
A Diagnosis
of Down Syndrome
A newborn baby with
Down syndrome often has physical features the attending physician will
most likely recognize in the delivery room. These may include a flat
facial profile, an upward slant to the eye, a short neck, abnormally
shaped ears, white spots on the iris of the eye (called Brushfield spots),
and a single, deep transverse crease on the palm of the hand. However,
a child with Down syndrome may not possess all of these features; some
of these features can even be found in the general population.
To confirm the diagnosis,
the doctor will request a blood test called a chromosomal karyotype.
This involves "growing" the cells from the baby's blood for
about two weeks, followed by a microscopic visualization of the chromosomes
to determine if extra material from chromosome 21 is present.
Medical care for
infants with Down syndrome should include the same well-baby care that
other children receive.
When parents are told that their newborn baby has Down syndrome, it
is not unusual for them to have feelings of sadness and disappointment.
Many parents report that at the time their child is first diagnosed
with Down syndrome and during the weeks that follow, they feel overwhelmed
by feelings of loss and anxiety. While caring for a child with Down
syndrome frequently requires more time and energy, parents of newborn
children with Down syndrome should seek the advice of a knowledgeable
pediatrician and/or the many Down syndrome support groups and organizations
available (see Additional Resources for a listing).
The doctor making
the initial diagnosis of Down syndrome has no way of knowing the intellectual
or physical capabilities this child, or any other child, may have. Children
and adults with Down syndrome have a wide range of abilities. A person
with Down syndrome may be very healthy or they may present unusual and
demanding medical and social problems at virtually every stage of life.
However, every person with Down syndrome is a unique individual, and
not all people with Down syndrome will develop all the medical disorders
discussed below.
Down Syndrome
and Associated Medical Disorders
During the first
days and months of life, some disorders may be immediately diagnosed.
Congenital hypothyroidism, characterized by a reduced basal metabolism,
an enlargement of the thyroid gland, and disturbances in the autonomic
nervous system, occurs slightly more frequently in babies with Down
syndrome. A routine blood test for hypothyroidism that is performed
on newborns will detect this condition if present.
Several other well-known
medical conditions, including hearing loss, congenital heart disease,
and vision disorders, are more prevalent among those with Down syndrome.
Recent studies indicate
that 66 to 89% of children with Down syndrome have a hearing loss of
greater than 15 to 20 decibels in at least one ear, due to the fact
that the external ear and the bones of the middle and inner ear may
develop differently in children with Down syndrome. Many hearing problems
can be corrected. But, because of the high prevalence of hearing loss
in children with Down syndrome, an objective measure of hearing should
be taken to establish hearing status. In addition to hearing disorders,
visual problems also may be present early in life. Cataracts occur in
approximately 3% of children with Down syndrome, but can be surgically
removed.
Approximately half
of the children with Down syndrome have congenital heart disease and
associated early onset of pulmonary hypertension, or high blood pressure
in the lungs. Echocardiography may be indicated to identify any congenital
heart disease. If the defects have been identified before the onset
of pulmonary hypertension, surgery has provided favorable results.
Seizure disorders,
though less prevalent than some of the other associated medical conditions,
still affect between 5 and 13% of individuals with Down syndrome, a
10-fold greater incidence than in the general population. There is an
unusually high incidence of infantile spasms or seizures in children
less than one year of age, some of which are precipitated by neonatal
complications and infections and cardiovascular disease. However, these
seizures can be treated with anti-epileptic drugs.
The incidence and
severity of these associated medical ailments will vary in babies with
Down syndrome and some may require surgery.
Newborns
Babies with Down
syndrome often have hypotonia, or poor muscle tone. Because they have
a reduced muscle tone and a protruding tongue, feeding babies with Down
syndrome usually takes longer. Mothers breast-feeding infants with Down
syndrome should seek advice from an expert on breast feeding to make
sure the baby is getting sufficient nutrition.
Hypotonia may affect
the muscles of the digestive system, in which case constipation may
be a problem. Atlantoaxial instability, a malformation of the upper
part of the spine located under the base of the skull, is present in
some individuals with Down syndrome. This condition can cause spinal
cord compression if it is not treated properly.
Infants
and Preschool Children
Medical care for
infants with Down syndrome should include the same well-baby care that
other children receive during the first years of life, as well as attention
to some problems that are more common in children with Down syndrome.
If heart, digestive, orthopedic or other medical conditions were identified
during the neonatal period, these problems should continue to be monitored.
During the early
years of life, children with Down syndrome are 10-15 times more likely
than other children to develop leukemia, a potentially fatal disease.
These children should receive an appropriate cancer therapy, such as
chemotherapy. Infants with Down syndrome are also more susceptible to
transient myelodysplasia, or the defective development of the spinal
cord.
Compared to the
general population, individuals with Down syndrome have a 12-fold higher
mortality rate from infectious diseases, if these infections are left
untreated and unmonitored. These infections are due to abnormalities
in their immune systems, usually the t-cell and antibody-mediated immunity
functions that fight off infections. Children with Down syndrome are
also more likely to develop chronic respiratory infections, middle ear
infections, and recurrent tonsillitis. In addition, there is a 62-fold
higher incidence of pneumonia in children with Down syndrome than in
the general population.
Children with Down
syndrome may be developmentally delayed. A child with Down syndrome
is often slow to turn over, sit, stand, and respond. This may be related
to the child's poor muscle tone. Development of speech and language
abilities may take longer than expected and may not occur as fully as
parents would like. However, children with Down syndrome do develop
the communication skills they need.
Parents of other
children with Down syndrome are often valuable sources of information
and support. Parents should keep in mind that children with Down syndrome
have a wide range of abilities and talents, and each child develops
at his or her own particular pace. It may take children with Down syndrome
longer than other children to reach develop mental milestones, but many
of these milestones will eventually be met. Parents should make a concerted
effort not to compare the developmental progress of a child with Down
syndrome to the progress of other siblings or even to other children
with Down syndrome.
Early Intervention
and Education
The term "early
intervention" refers to an array of specialized programs and related
resources that are made available by health care professionals to the
child with Down syndrome. These health care professionals may include
special educators, speech therapists, occupational therapists, and social
workers. It is recommended that stimulation and encouragement be provided
to children with Down syndrome.
The evaluation of
early intervention programs for children with Down syndrome is difficult,
due to the wide variety of experimental designs used in interventions,
the limited existing measures available that chart the progress of disabled
infants, and the tremendous variability in the developmental progress
among children with Down syndrome, a consequence in part of the many
complicating medical factors. While many studies have been conducted
to assess the effects of early intervention, the information is limited
and contradictory regarding the long-term success of early intervention
for children with Down syndrome.
However, federal
laws (Public Law 94-12) are in place to ensure each state has as a goal
that "all handicapped children have available to them a free public
education and related services designed to meet their unique needs."
The decision of what type of school a child with Down syndrome should
attend is an important one, made by the parents in consultation with
health and education professionals. A parent must decide between enrolling
the child in a school where most of the children do not have disabilities
(inclusion) or sending the child to a school for children with special
needs. Inclusion has become more common over the past decade.
Adolescence
Like all teenagers,
individuals with Down syndrome undergo hormonal changes during adolescence.
Therefore, teenagers with Down syndrome should be educated about their
sexual drives. Scientists have medical evidence that males with Down
syndrome generally have a reduced sperm count and rarely father children.
Females with Down syndrome have regular menstrual periods and are capable
of becoming pregnant and carrying a baby to term.
Adults with
Down Syndrome
The life expectancy
for people with Down syndrome has increased substantially. In 1929,
the average life span of a person with Down syndrome was nine years.
Today, it is common for a person with Down syndrome to live to age fifty
and beyond. In addition to living longer, people with Down syndrome
are now living fuller, richer lives than ever before as family members
and contributors to their community. Many people with Down syndrome
form meaningful relationships and eventually marry. Now that people
with Down syndrome are living longer, the needs of adults with Down
syndrome are receiving greater attention. With assistance from family
and caretakers, many adults with Down syndrome have developed the skills
required to hold jobs and to live semi-independently.
Premature aging
is a characteristic of adults with Down syndrome. In addition, dementia,
or memory loss and impaired judgment similar to that occurring in Alzheimer
disease patients, may appear in adults with Down syndrome. This condition
often occurs when the person is younger than forty years old. Family
members and caretakers of an adult with Down syndrome must be prepared
to intervene if the individual begins to lose the skills required for
independent living.
Down Syndrome
in the Workplace
The Americans with
Disabilities Act (ADA) makes it illegal for an employer of more than
15 individuals to discriminate against qualified individuals in application
procedures, hiring, advancement, discharge, compensation, job training,
and other terms of employment. The ADA requires that an employer provide
reasonable accommodation for individuals who are qualified for a position.
More information about the ADA can be obtained from the Office of Civil
Rights of the U.S. Department of Health and Human Services, Washington,
DC, 20201.
Future Directions
in Down Syndrome Research
Recently, it has
been suggested that children with Down syndrome might benefit from medical
intervention that includes amino acid supplements and a drug known as
Piracetam. Piracetam is a psychoactive drug that some believe may improve
cognitive function. However, there have been no controlled clinical
studies conducted to date using Piracetam to treat Down syndrome in
the U.S. or elsewhere that show its safety and efficacy.
Down syndrome researchers
have developed a mouse model to analyze the developmental consequences
of Down syndrome. Mice are used because a large stretch of mouse chromosome
16 has many genes in common with those on human chromosome 21. Studying
these models at varying stages of development will enhance our basic
understanding of Down syndrome and facilitate the development of effective
interventions and treatment strategies.
Questions and Answers
about Down Syndrome
Is Down syndrome
a rare genetic disorder?
Down syndrome occurs
in 1 in 800 births.
Do only
older women give birth to babies with Down syndrome?
Researchers have
established that the likelihood that a reproductive cell will contain
an extra copy of chromosome 21 increases dramatically as a woman ages.
Therefore, an older mother is more likely than a younger mother to have
a baby with Down syndrome, but older mothers account for only about
9% of all live births each year and 25% of Down syndrome births.
Are all
people with Down syndrome severely retarded?
Most people with
Down syndrome have IQ's that fall in the mild to moderate range of retardation.
Some are so mildly affected that they live independently and are gainfully
employed.
Can people
with Down syndrome receive proper care at home?
Home-based care
and community living give them the opportunity to socialize and benefit
from such interactions.
Should all
children with Down syndrome be placed in special education classrooms?
While federal laws
have been established to ensure that all handicapped children have access
to public education, children with Down syndrome can and have been included
into a regular classroom.
Is there
a cure for Down syndrome?
Researchers have
identified the genes that cause the characteristics of Down syndrome
and are working to further develop mouse models, at varying stages of
development, in order to enhance their basic understanding of Down syndrome
and facilitate the development of effective interventions and treatment
strategies.
Additional
Resources for Down Syndrome
INFORMATION
AND ASSISTANCE
|
Administration
on Developmental Disabilities
Administration for Children and Families
U.S. Department of Health and Human Services
Mail Stop: HHH 300F
370 L’Enfant Promenade S.W.
Washington, DC 20447
(202) 690-6590
http://www.acf.dhhs.gov/programs/add/
American
Speech, Language and Hearing
Association
10801 Rockville Pike
Rockville, MD 20852
1-800-638-8255 or 1-888-321-ASHA
http://www.asha.org/
Learning
Disabilities Association of America
4156 Library Road
Pittsburgh, PA 15234-1349
(412) 341-1515 or 1-888-300-6710
http://www.ldanatl.org/
March
of Dimes
1275 Mamaroneck Avenue
White Plains, NY 10605
(914) 428-7100
1-888-MODIMES (1-888-663-4637)
http://www.modimes.org/
National
Down Syndrome Congress
1370 Center Drive, Suite 102
Atlanta, GA 30338
1-800-232-6372
(770) 604-9500
http://www.ndsccenter.org/
|
National
Down Syndrome Society
666 Broadway
New York, NY 10012
1-800-221-4602
(212) 460-9330
http://www.ndss.org/
National
Information Center for Children
and Youth with Disabilities
P.O. Box 1492
Washington, DC 20013-1492
1-800-695-0285
(202) 884-8200
http://www.nichcy.org/
Mid-Atlantic
Regional
Human Genetics Network (MARHGN)
(genetic counseling)
Curtis Coughlin II, MS, MARHGN Coordinator
MARGHN c/o Christiana Health Care Services
Genetics Room 1988
4755 Ogletown-Stanton Road
P.O. Box 6001
Newark, DE 19718
(302) 733-6732
http://www.pitt.edu/~marhgn/
National
Society of Genetic Counselors
233 Canterbury Drive
Wallingford, PA 19086-6617
(610) 872-7608
http://www.nsgc.org/
The
Arc of the United States
1010 Wayne Avenue, Suite 650
Silver Spring, MD 20910
(301) 565-3842
(301) 565-3843 - Fax
http://www.thearc.org
|
Site Design © DSAGNO 2002